日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety and Efficacy of Vidofludimus Calcium in Patients Hospitalized with COVID-19: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial

Vidofludimus Calcium 在 COVID-19 住院患者中的安全性和有效性：一项双盲、随机、安慰剂对照的 II 期试验

期刊:Infectious Diseases and Therapy
影响因子:5.3
doi:10.1007/s40121-022-00690-0
Vehreschild, Maria J G T; Atanasov, Petar; Yurko, Kateryna; Oancea, Cristian; Popov, Georgi; Smesnoi, Valentina; Placinta, Gheorghe; Kohlhof, Hella; Vitt, Daniel; Peelen, Evelyn; Mihajlović, Jelena; Muehler, Andreas R
GPCR/Calcium/cAMP
发表日期：2022
文献求助 收藏

HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection

在以NAP为基础的治疗方案中，HBeAg阴性慢性HBV和HBV/HDV感染期间HBsAg亚型的动态变化

期刊:Hepatology Communications
影响因子:4.6
doi:10.1002/hep4.1951
Bazinet, Michel; Anderson, Mark; Pântea, Victor; Placinta, Gheorghe; Moscalu, Iurie; Cebotarescu, Valentin; Cojuhari, Lilia; Jimbei, Pavlina; Iarovoi, Liviu; Smesnoi, Valentina; Musteata, Tatina; Jucov, Alina; Dittmer, Ulf; Gersch, Jeff; Holzmayer, Vera; Kuhns, Mary; Cloherty, Gavin; Vaillant, Andrew
炎症/感染
发表日期：2022
文献求助 收藏

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy

在基于NAP的治疗期间及治疗后持续存在的HBsAg免疫复合物和cccDNA活性的分析

期刊:Hepatology Communications
影响因子:4.6
doi:10.1002/hep4.1767
Bazinet, Michel; Anderson, Mark; Pântea, Victor; Placinta, Gheorghe; Moscalu, Iurie; Cebotarescu, Valentin; Cojuhari, Lilia; Jimbei, Pavlina; Iarovoi, Liviu; Smesnoi, Valentina; Musteata, Tatina; Jucov, Alina; Dittmer, Ulf; Gersch, Jeff; Holzmayer, Vera; Kuhns, Mary; Cloherty, Gavin; Vaillant, Andrew
免疫/内分泌
发表日期：2021
文献求助 收藏